| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |